Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

INVO Fertility (IVF) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for INVO Fertility (IVF) over the last 17 years, with Q3 2025 value amounting to 91.29%.

  • INVO Fertility's EBITDA Margin fell 23800.0% to 91.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 361.13%, marking a year-over-year decrease of 2636000.0%. This contributed to the annual value of 122.83% for FY2024, which is 985400.0% up from last year.
  • As of Q3 2025, INVO Fertility's EBITDA Margin stood at 91.29%, which was down 23800.0% from 158.76% recorded in Q2 2025.
  • INVO Fertility's EBITDA Margin's 5-year high stood at 16.89% during Q4 2021, with a 5-year trough of 1820.37% in Q2 2022.
  • In the last 5 years, INVO Fertility's EBITDA Margin had a median value of 227.51% in 2021 and averaged 576.07%.
  • In the last 5 years, INVO Fertility's EBITDA Margin crashed by -14290400bps in 2022 and then soared by 11726100bps in 2023.
  • Over the past 5 years, INVO Fertility's EBITDA Margin (Quarter) stood at 16.89% in 2021, then tumbled by -5843bps to 970.3% in 2022, then soared by 89bps to 107.65% in 2023, then plummeted by -89bps to 203.84% in 2024, then soared by 55bps to 91.29% in 2025.
  • Its EBITDA Margin was 91.29% in Q3 2025, compared to 158.76% in Q2 2025 and 1043.09% in Q1 2025.